Successful use of continuous subcutaneous hydrocortisone infusion after bilateral adrenalectomy secondary to bilateral pheochromocytoma

J Pediatr Endocrinol Metab. 2015 Jul;28(7-8):947-9. doi: 10.1515/jpem-2014-0473.

Abstract

We report the use of continuous subcutaneous hydrocortisone infusion in an adolescent patient with primary adrenal insufficiency. This novel hydrocortisone delivery method proved to be a feasible, well-tolerated and safe option for selected patients with poor response to conventional therapy.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Adrenal Gland Neoplasms / pathology
  • Adrenal Gland Neoplasms / surgery*
  • Adrenalectomy / adverse effects*
  • Humans
  • Hydrocortisone / administration & dosage*
  • Infusions, Subcutaneous
  • Male
  • Pheochromocytoma / pathology
  • Pheochromocytoma / surgery*
  • Postoperative Complications / drug therapy*
  • Prognosis

Substances

  • Hydrocortisone